The International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) model as a prognostic tool in metastatic renal cell carcinoma (mRCC) patients previously treated with first-line targeted therapy (TT)

被引：0
作者：
Ko, Jenny J.
Xie, Wanling
Heng, Daniel Yick Chin
Kroeger, Nils
Lee, Jae-Lyun
Rini, Brian I.
Knox, Jennifer J.
Bjarnason, Georg A.
Harshman, Lauren Christine
Pal, Sumanta Kumar
Yuasa, Takeshi
Smoragiewicz, Martin
Donskov, Frede
Bamias, Aristotelis
Wood, Lori
Ernst, D. Scott
Agarwal, Neeraj
Vaishampayan, Ulka N.
Rha, Sun Young
Choueiri, Toni K.
机构：
[1] Tom Baker Canc Clin, Calgary, AB, Canada
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
[4] Univ Med Greifswald, Dept Urol, Greifswald, Germany
[5] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
[6] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[7] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Dept Med, Toronto, ON, Canada
[8] Univ Toronto, Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[9] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[10] City Hope Natl Med Ctr, Duarte, CA 91010 USA
[11] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Urol, Tokyo, Japan
[12] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[13] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus, Denmark
[14] Alexandra Peripheral Gen Hosp, Athens, Greece
[15] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada
[16] London Reg Canc Ctr, London, ON N6A 4L6, Canada
[17] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[18] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
[19] Yonsei Univ, Coll Med, Seoul, South Korea
[20] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 04期
关键词：
D O I：
10.1200/jco.2014.32.4_suppl.398
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
398
引用
收藏
页数：1
相关论文
共 50 条
[31]   Updated outcomes of patients with metastatic non-clear cell renal cell carcinoma (mnccRCC) treated with first-line (1L) therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC). [J].
Takemura, Kosuke ;
Graham, Jeffrey ;
Maj, David ;
Zarba, Martin ;
Wells, Connor ;
Chehade, Razane El Hajj ;
Eid, Marc ;
Saad, Eddy ;
Saliby, Renee Maria ;
Lee, Jae Lyun ;
Donskov, Frede ;
Beuselinck, Benoit ;
Jude, Evon ;
McKay, Rana R. ;
Basappa, Naveen S. ;
Pal, Sumanta Kumar ;
Porta, Camillo ;
Agarwal, Neeraj ;
Choueiri, Toni K. ;
Heng, Daniel Yick Chin .
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
[32]   Characterization of Patients With Metastatic Renal Cell Carcinoma Experiencing Complete Response to First-line Therapies: Results From the International Metastatic Renal Cell Carcinoma Database Consortium [J].
Takemura, Kosuke ;
Navani, Vishal ;
Ernst, Matthew S. S. ;
Wells, J. Connor ;
Meza, Luis ;
Pal, Sumanta K. K. ;
Lee, Jae-Lyun ;
Li, Haoran ;
Agarwal, Neeraj ;
Alva, Ajjai S. S. ;
Hansen, Aaron R. R. ;
Basappa, Naveen S. S. ;
Szabados, Bernadett ;
Powles, Thomas ;
Tran, Ben ;
Hocking, Christopher M. M. ;
Beuselinck, Benoit ;
Yuasa, Takeshi ;
Choueiri, Toni K. K. ;
Heng, Daniel Y. C. .
JOURNAL OF UROLOGY, 2023, 209 (04) :701-709
[33]   Sites of metastasis and survival in metastatic renal-cell carcinoma (mRCC): Resuits from the international mRCC Database Consortium (IMDC) [J].
Dudani, Shaan ;
de Velasco, Guillermo ;
Wells, J. Connor ;
Gan, Chun Loo ;
Donskov, Frede ;
Porta, Camillo ;
Fraccon, Anna ;
Pasini, Felice ;
Hansen, Aaron ;
Bjarnason, Georg ;
Beuselinck, Benoit ;
Pal, Sumanta K. ;
Hotte, Sebastien ;
Lalani, Aly-Khan A. ;
Yuasa, Takeshi ;
Kanesvaran, Ravindran ;
Reaume, M. Neil ;
Canil, Christina ;
Choueiri, Toni K. ;
Heng, Daniel Y. C. .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 :4-4
[34]   First-, second-, third-line therapy for metastatic renal cell carcinoma (mRCC): Benchmarks for trials design from the International mRCC Database Consortium (IMDC) [J].
Heng, Daniel Yick Chin ;
Rini, Brian I. ;
Lee, Jae-Lyun ;
Kroeger, Nils ;
Srinivas, Sandy ;
Harshman, Lauren Christine ;
Knox, Jennifer J. ;
Bjarnason, Georg A. ;
MacKenzie, Mary J. ;
Wood, Lori ;
Vaishampayan, Ulka N. ;
Agarwal, Neeraj ;
Pal, Sumanta Kumar ;
Tan, Min-Han ;
Rha, Sun Young ;
Yuasa, Takeshi ;
Donskov, Frede ;
Bamias, Aristotelis ;
North, Scott A. ;
Choueiri, Toni K. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[35]   Additional biological and clinical characteristics to refine International Metastatic RCC Database Consortium (IMDC) prognostic/predictive assessment in metastatic renal cell carcinoma (mRCC). [J].
Zampiva, Ilaria ;
Merler, Sara ;
Inzerilli, Nicola ;
Zacchi, Francesca ;
Manduca, Stefano ;
Pafumi, Sarah ;
Piacentini, Michela ;
Marletta, Stefano ;
Incani, Ursula Cesta ;
Torroni, Lorena ;
Vesentini, Roberta ;
Marchetti, Pierpaolo ;
Fantinel, Emanuela ;
Zivi, Andrea ;
Calio, Anna ;
Brunelli, Matteo ;
Verlato, Giuseppe ;
Milella, Michele .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
[36]   TOLERABILITY OF TARGETED AGENTS IN FIRST-LINE TREATMENT OF METASTATIC RENAL CELL CARCINOMA (MRCC) [J].
Su, Y. ;
Shi, N. ;
Landsman-Blumberg, P. ;
Poehlein, C. ;
Waxman, I. .
ANNALS OF ONCOLOGY, 2012, 23 :267-268
[37]   The impact of impaired renal function on the effectiveness of first-line immuno-oncology combination therapies in metastatic renal cell carcinoma (mRCC): Results from the international metastatic RCC database consortium (IMDC) [J].
Navani, V. ;
Ernst, M. S. ;
Takemura, K. ;
Pal, S. K. ;
Powles, T. B. ;
Donskov, F. ;
Wells, J. C. ;
Kollmannsberger, C. K. ;
Beuselinck, B. ;
Alva, A. S. ;
Weickhardt, A. J. ;
Lalani, A-K. ;
Ernst, D. S. ;
Agarwal, N. ;
Choueiri, T. K. ;
Heng, D. Y. C. .
ANNALS OF ONCOLOGY, 2022, 33 (07) :S1215-S1216
[38]   CLINICAL HETEROGENEITY AMONG FIRST-LINE SUNITINIB PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) CATEGORIZED AS INTERMEDIATE RISK (IR) GROUP ACCORDING TO THE INTERNATIONAL MRCC DATABASE CONSORTIUM (IMDC) RISK MODEL [J].
Huynh, L. ;
Wells, J. C. ;
Graham, J. ;
Steinharter, J. ;
McGregor, B. ;
Donskov, F. ;
Bjarnason, G. A. ;
Vaishampayan, U. ;
Hansen, A. ;
Iafolla, M. ;
Zanotti, G. ;
Chang, R. ;
Cheng, W. Y. ;
Duh, M. S. ;
Heng, D. Y. C. .
VALUE IN HEALTH, 2019, 22 :S59-S60
[39]   Prognostic significance of absolute lymphocyte count in patients with metastatic renal cell carcinoma receiving first-line combination immunotherapies: results from the International Metastatic Renal Cell Carcinoma Database Consortium [J].
Takemura, K. ;
Yuasa, T. ;
Lemelin, A. ;
Ferrier, E. ;
Wells, J. C. ;
Saad, E. ;
Saliby, R. M. ;
Basappa, N. S. ;
Wood, L. A. ;
Jude, E. ;
Pal, S. K. ;
Donskov, F. ;
Beuselinck, B. ;
Szabados, B. ;
Powles, T. ;
McKay, R. R. ;
Gebrael, G. ;
Agarwal, N. ;
Choueiri, T. K. ;
Heng, D. Y. C. .
ESMO OPEN, 2024, 9 (07)
[40]   Prognostic factors for overall survival with sunitinib as first-line therapy in patients with metastatic renal cell carcinoma (mRCC) [J].
Patil, S. ;
Figlin, R. A. ;
Hutson, T. E. ;
Michaelson, M. D. ;
Negrier, S. ;
Kim, S. T. ;
Huang, X. ;
Motzer, R. J. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345